These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6783287)
61. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa. Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508 [TBL] [Abstract][Full Text] [Related]
62. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa. Syeklocha D Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781 [No Abstract] [Full Text] [Related]
63. Immunological studies of an artificial antigen with specificity of a common polysaccharide antigen of Pseudomonas aeruginosa. Makarenko TA; Kocharova NA; Edvabnaya LS; Tsvetkov YE; Kholodkova EV; Knirel YA; Backinowsky LV; Kochetkov NK; Stanislavsky ES FEMS Immunol Med Microbiol; 1993 Oct; 7(3):251-6. PubMed ID: 7506094 [TBL] [Abstract][Full Text] [Related]
64. Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection. Hirao Y; Homma JY Jpn J Exp Med; 1978 Feb; 48(1):41-51. PubMed ID: 97424 [TBL] [Abstract][Full Text] [Related]
65. [Experimental infection of immunized mice homologous and heterologous serotypes with Pseudomonas aeruginosa]. Vidal G; Mynard MC Ann Inst Pasteur (Paris); 1972 Jun; 122(6):1129-35. PubMed ID: 4627762 [No Abstract] [Full Text] [Related]
66. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa. Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Lombardo D; Miner KM; Puckett JM; Sewell TJ; Sigal NH Infect Immun; 1988 Aug; 56(8):1873-9. PubMed ID: 3135264 [TBL] [Abstract][Full Text] [Related]
67. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420 [TBL] [Abstract][Full Text] [Related]
68. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins. Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393 [TBL] [Abstract][Full Text] [Related]
77. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231 [TBL] [Abstract][Full Text] [Related]
78. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. Pennington JE; Hickey WF; Blackwood LL; Arnaut MA J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229 [TBL] [Abstract][Full Text] [Related]
79. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations. Holder IA; Naglich JG J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208 [TBL] [Abstract][Full Text] [Related]
80. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice]. Trautmann M; Brückner O; Hahn H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]